GlassScriptPhysician profile
Sara Lenherr
NPI 1801067954
$12,434.82
in general payments reported to CMS, 2019-2025
9 companies · $4,938 in 2025
The $4,938 reported for 2025 was more than what 90% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $294 · 2020: $217 · 2021: $186 · 2022: $158 · 2023: $2,534 · 2024: $4,109 · 2025: $4,938.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $6,961 · Consulting Fee: $1,800 · Food and Beverage: $1,454 · Travel and Lodging: $1,146 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $220.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $6,961.16 |
| Consulting Fee | $1,800.00 |
| Food and Beverage | $1,454.16 |
| Travel and Lodging | $1,145.73 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $220.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hollister Incorporated | $7,058.15 | 2023-2025 | |
| Bluewind Medical | $1,853.02 | 2024 | Revi |
| Medtronic, INC. | $1,253.42 | 2022-2025 | Altaviva, Interstim |
| Boston Scientific Corporation | $1,044.40 | 2019-2025 | Ams 800 Artificial Urinary Sphincter, Ams 700 Cxr Rte Kit, Lithovue |
| Axonics, INC. | $701.72 | 2021-2024 | Bulkamid, Axonics |
| Sumitomo Pharma America, INC. | $230.99 | 2023-2025 | Gemtesa |
| Allergan, INC. | $156.42 | 2020 | |
| Coloplast Corp | $114.99 | 2022-2025 | |
| Laborie Medical Technologies Corp. | $21.71 | 2024 | Urgent PC Neuromodulation System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Lenherr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.